Zonal-centrifuged human diploid cell rabies vaccine. 1976

M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen

In order to reduce the risk of allergic reactions, a purified human diploid cell culture rabies vaccine was developed. Pitman-Moore strain of rabies was propagated in WI-38 or MRC-5 cells. Both cell strains were found to be equally suitable for pro agation of rabies virus. The virus was purified and concentrated by continuous-flow sucrose density gradient ultracentrifugation. Virus peak fractions were diluted with a stabilized and then inactivated with BPL and freeze-dried. According to the standard NIH test for potency, the vaccine proved to be very potent and stable. The results of initial clinical applications of the vaccine will be presented.

UI MeSH Term Description Entries
D011420 Propiolactone Disinfectant used in vapor form to sterilize vaccines, grafts, etc. The vapor is very irritating and the liquid form is carcinogenic. Propanolide,beta-Propiolactone,beta Propiolactone
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002501 Centrifugation, Zonal Centrifugation using a rotating chamber of large capacity in which to separate cell organelles by density-gradient centrifugation. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Centrifugations, Zonal,Zonal Centrifugation,Zonal Centrifugations
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004171 Diploidy The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X. Diploid,Diploid Cell,Cell, Diploid,Cells, Diploid,Diploid Cells,Diploidies,Diploids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity

Related Publications

M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
September 1971, Applied microbiology,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
October 1980, The Medical letter on drugs and therapeutics,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
June 1977, The Veterinary record,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
March 1984, Journal of the American Veterinary Medical Association,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
February 1985, Lancet (London, England),
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
December 1982, JAMA,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
May 1979, Canadian Medical Association journal,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
September 1979, American journal of epidemiology,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
April 1976, British medical journal,
M Majer, and J Hilfenhaus, and R Mauler, and W Hennessen
March 1974, Applied microbiology,
Copied contents to your clipboard!